Literature DB >> 16597186

Mortality in Prader-Willi syndrome.

Stewart L Einfeld1, Sophie J Kavanagh, Arabella Smith, Elizabeth J Evans, Bruce J Tonge, John Taffe.   

Abstract

Persons with Prader-Willi syndrome have been known to have a high mortality rate. However, intellectual disability, which usually accompanies Prader-Willi syndrome, is also associated with a higher mortality rate than in the general population. In this study, the death rates in a longitudinal cohort of people with Prader-Willi syndrome are compared with those for an epidemiologically derived control sample of people with intellectual disability from other causes. We found that those with Prader-Willi syndrome had a higher mortality rate than did controls. After the protective effect of mild intellectual disability or average intellectual function was accounted for, the hazard ratio for Prader-Willi syndrome versus controls was 6.07. Obesity and its complications were factors contributing to the mortality identified in this study.

Entities:  

Mesh:

Year:  2006        PMID: 16597186      PMCID: PMC2422866          DOI: 10.1352/0895-8017(2006)111[193:MIPS]2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  22 in total

1.  Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy.

Authors:  A Smith; G Loughnan; K Steinbeck
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

2.  Population prevalence of psychopathology in children and adolescents with intellectual disability: I. Rationale and methods.

Authors:  S L Einfeld; B J Tonge
Journal:  J Intellect Disabil Res       Date:  1996-04

3.  Adults with Prader-Willi syndrome: a survey of 232 cases.

Authors:  L R Greenswag
Journal:  Dev Med Child Neurol       Date:  1987-04       Impact factor: 5.449

4.  Mortality of the mentally deficient: a study of 12,903 institutionalised subjects.

Authors:  H Forssman; H O Akesson
Journal:  J Ment Defic Res       Date:  1970-12

Review 5.  A comprehensive team approach to the management of patients with Prader-Willi syndrome.

Authors:  Urs Eiholzer; Barbara Y Whitman
Journal:  J Pediatr Endocrinol Metab       Date:  2004-09       Impact factor: 1.634

Review 6.  Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.

Authors:  David B Allen; Aaron L Carrel
Journal:  J Pediatr Endocrinol Metab       Date:  2004-09       Impact factor: 1.634

Review 7.  Sudden death in growth hormone-treated children with Prader-Willi syndrome.

Authors:  Guy Van Vliet; Cheri L Deal; Patricia A Crock; Yves Robitaille; Luc L Oligny
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

8.  Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders.

Authors:  Annick Vogels; Jenneke Van Den Ende; Kathelijne Keymolen; Geert Mortier; Koen Devriendt; E Legius; J P Fryns
Journal:  Eur J Hum Genet       Date:  2004-03       Impact factor: 4.246

9.  Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals.

Authors:  David A Stevenson; Theresa M Anaya; Jill Clayton-Smith; Bryan D Hall; Margot I Van Allen; Roberto T Zori; Elaine H Zackai; Gary Frank; Carol L Clericuzio
Journal:  Am J Med Genet A       Date:  2004-01-15       Impact factor: 2.802

10.  Population prevalence of psychopathology in children and adolescents with intellectual disability: II. Epidemiological findings.

Authors:  S L Einfeld; B J Tonge
Journal:  J Intellect Disabil Res       Date:  1996-04
View more
  32 in total

1.  Sleeve gastrectomy leads to weight loss in the Magel2 knockout mouse.

Authors:  Deanna M Arble; Joshua W Pressler; Joyce Sorrell; Rachel Wevrick; Darleen A Sandoval
Journal:  Surg Obes Relat Dis       Date:  2016-04-27       Impact factor: 4.734

2.  Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark.

Authors:  E Hedgeman; S P Ulrichsen; S Carter; N C Kreher; K P Malobisky; M M Braun; J Fryzek; M S Olsen
Journal:  Int J Obes (Lond)       Date:  2017-06-21       Impact factor: 5.095

3.  Contributing factors of mortality in Prader-Willi syndrome.

Authors:  Jennifer Proffitt; Kathryn Osann; Barbara McManus; Virginia E Kimonis; Janalee Heinemann; Merlin G Butler; David A Stevenson; June-Anne Gold
Journal:  Am J Med Genet A       Date:  2018-12-19       Impact factor: 2.802

4.  Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.

Authors:  Dong-Kyu Jin
Journal:  Korean J Pediatr       Date:  2012-07-17

5.  Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study.

Authors:  Aayed R Alqahtani; Mohamed O Elahmedi; Awadh R Al Qahtani; Jaehoon Lee; Merlin G Butler
Journal:  Surg Obes Relat Dis       Date:  2015-07-22       Impact factor: 4.734

Review 6.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

7.  Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome.

Authors:  L A Gondoni; L Vismara; P Marzullo; R Vettor; A Liuzzi; G Grugni
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

8.  Clinical management of behavioral characteristics of Prader-Willi syndrome.

Authors:  Alan Y Ho; Anastasia Dimitropoulos
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Daniel J Driscoll
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

10.  Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects.

Authors:  A Caixàs; O Giménez-Palop; M Broch; C Vilardell; A Megía; I Simón; G Giménez-Pérez; D Mauricio; J Vendrell; C Richart; J M González-Clemente
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.